MedPath

Pilot Study of the Modified Atkins Diet for Tourette Syndrome

Phase 1
Terminated
Conditions
Tourette Syndrome
Interventions
Dietary Supplement: Modified Atkins diet
Registration Number
NCT00952601
Lead Sponsor
Johns Hopkins University
Brief Summary

Pharmacotherapy has long been considered the primary approach for tic suppression in Tourette syndrome (TS). Unfortunately, medications are often ineffective and frequently have significant side-effects. This is a pilot therapeutic study using a dietary approach, the modified Atkins diet (MAD). The goal of this study is to establish the safety, tolerability, and efficacy of dietary therapy in patients with TS ("proof of concept") and to determine whether this intervention is worthy of evaluation in large-scale clinical trials. The modified Atkins diet mimics the well established ketogenic diet, but in a less-restrictive dietary manner. Dietary approaches using the MAD/ketogenic diet are currently under investigation for neurological conditions other than epilepsy, including Alzheimer disease, headaches, autism, narcolepsy, brain tumors, traumatic brain injury, Parkinson's disease, and depression.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Ages 12-65 years
  • Tourette syndrome (vocal and motor tics for over a year)
  • > 20 score on the Yale Global Tic Severity Scale
  • Ability to follow instructions and comply with the dietary changes
Read More
Exclusion Criteria
  • Secondary tics
  • Underweight (BMI < 5%)
  • Prior use of the Atkins diet for over 2 days
  • High cholesterol or triglycerides
  • Major depression or anxiety disorder
  • Pregnancy
  • Substance abuse
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Modified Atkins DietModified Atkins dietPatients are started on the modified Atkins diet at 15 grams per day.
Primary Outcome Measures
NameTimeMethod
Tic frequency2 months

Number of tics per day, intensity, severity, will be compared to baseline (pre-diet)

Secondary Outcome Measures
NameTimeMethod
Ketosis2 months

Trial Locations

Locations (1)

Johns Hopkins Hospital

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath